Literature DB >> 23614764

Pulmonary hypertension in patients with chronic myeloproliferative neoplasms.

Safia Chebrek1, Karim Aïssi, Yves Francès, Cédric Mercier, Laure Farnault, Gérard Sébahoun, Régis Costello.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23614764     DOI： 10.3109/10428194.2013.797083

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  8 in total

1.  Prevalence of pulmonary hypertension in myelofibrosis.

Authors:  Juan Lopez-Mattei; Srdan Verstovsek; Bryan Fellman; Cezar Iliescu; Karan Bhatti; Saamir A Hassan; Peter Kim; Brian A Gray; Nicolas L Palaskas; Horiana B Grosu; Mamas A Mamas; Saadia A Faiz
Journal:  Ann Hematol       Date:  2020-02-19       Impact factor: 4.030

2.  Association of Disease Subtype and Duration with Echocardiographic Evidence of Pulmonary Hypertension in Myeloproliferative Neoplasm.

Authors:  Yalin Tolga Yaylali; Samet Yilmaz; Gulsum Akgun-Cagliyan; Oguz Kilic; Emrah Kaya; Hande Senol; Furkan Ozen
Journal:  Med Princ Pract       Date:  2020-02-19       Impact factor: 1.927

Review 3.  Hematological disorders and pulmonary hypertension.

Authors:  Rajamma Mathew; Jing Huang; Joseph M Wu; John T Fallon; Michael H Gewitz
Journal:  World J Cardiol       Date:  2016-12-26

4.  Pulmonary Hypertension Associated with Pulmonary Veno-occlusive Disease in Patients with Polycythemia Vera.

Authors:  Takayoshi Tachibana; Naoki Nakayama; Ayako Matsumura; Yuki Nakajima; Hiroyuki Takahashi; Takuya Miyazaki; Hideaki Nakajima
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271

5.  Pulmonary hypertension in patients with Philadelphia-negative myeloproliferative neoplasms: a single-center retrospective analysis of 225 patients.

Authors:  Myeong-Won Lee; Hyewon Ryu; Yoon-Seok Choi; Ik-Chan Song; Hyo-Jin Lee; Hwan-Jung Yun; Byung Joo Sun; Jin-Ok Jeong; Deog-Yeon Jo
Journal:  Blood Res       Date:  2020-06-30

6.  Pulmonary hypertension with massive megalosplenia: A case report.

Authors:  Tieci Yi; Wei Ma; Jianxing Qiu; Wenhui Ding
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 7.  Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.

Authors:  Mazen Al-Qadi; Barbara LeVarge; H James Ford
Journal:  Front Med (Lausanne)       Date:  2021-03-25

8.  Screening for precapillary pulmonary hypertension in chronic myeloproliferative disorders: the role of N-terminal pro-B-type natriuretic peptide and vascular endothelial growth factor - a pilot study.

Authors:  Gyöngyvér Költő; Margit Tőkés-Füzesi; Előd Papp; Zsófia Adravetz; András Komócsi; Miklós Egyed; Réka Faludi
Journal:  Arch Med Sci       Date:  2020-02-27       Impact factor: 3.318
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.